Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 23897585)

1.

Circulating pro-surfactant protein B as a risk biomarker for lung cancer.

Taguchi A, Hanash S, Rundle A, McKeague IW, Tang D, Darakjy S, Gaziano JM, Sesso HD, Perera F.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1756-61. doi: 10.1158/1055-9965.EPI-13-0251. Epub 2013 Jul 29.

2.

Pro-surfactant protein B as a biomarker for lung cancer prediction.

Sin DD, Tammemagi CM, Lam S, Barnett MJ, Duan X, Tam A, Auman H, Feng Z, Goodman GE, Hanash S, Taguchi A.

J Clin Oncol. 2013 Dec 20;31(36):4536-43. doi: 10.1200/JCO.2013.50.6105. Epub 2013 Nov 18.

3.
4.

Plasma pro-surfactant protein B and lung function decline in smokers.

Leung JM, Mayo J, Tan W, Tammemagi CM, Liu G, Peacock S, Shepherd FA, Goffin J, Goss G, Nicholas G, Tremblay A, Johnston M, Martel S, Laberge F, Bhatia R, Roberts H, Burrowes P, Manos D, Stewart L, Gingras M, Pasian S, Tsao MS, Lam S, Sin DD; Pan-Canadian Early Lung Cancer Study Group.

Eur Respir J. 2015 Apr;45(4):1037-45. doi: 10.1183/09031936.00184214. Epub 2015 Jan 22.

PMID:
25614175
5.

Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.

Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng YL, Bowman ED, Engels EA, Caporaso NE, Harris CC.

J Natl Cancer Inst. 2011 Jul 20;103(14):1112-22. doi: 10.1093/jnci/djr216. Epub 2011 Jun 17.

6.
7.

Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.

Yu H, Spitz MR, Mistry J, Gu J, Hong WK, Wu X.

J Natl Cancer Inst. 1999 Jan 20;91(2):151-6.

8.

Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China.

Yuan JM, Ross RK, Chu XD, Gao YT, Yu MC.

Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):767-73.

9.

beta-carotene-induced changes in RARbeta isoform mRNA expression patterns do not influence lung adenoma multiplicity in the NNK-initiated A/J mouse model.

Goralczyk R, Bachmann H, Wertz K, Lenz B, Riss G, Buchwald Hunziker P, Greatrix B, Aebischer CP.

Nutr Cancer. 2006;54(2):252-62.

PMID:
16898870
10.

Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance.

Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Palmgren J, Freedman LS, Haapakoski J, Barrett MJ, Pietinen P, Malila N, Tala E, Liippo K, Salomaa ER, Tangrea JA, Teppo L, Askin FB, Taskinen E, Erozan Y, Greenwald P, Huttunen JK.

J Natl Cancer Inst. 1996 Nov 6;88(21):1560-70.

11.

Ionizing radiation-induced γ-H2AX activity in whole blood culture and the risk of lung cancer.

He Y, Gong Y, Lin J, Chang DW, Gu J, Roth JA, Wu X.

Cancer Epidemiol Biomarkers Prev. 2013 Mar;22(3):443-51. doi: 10.1158/1055-9965.EPI-12-0794. Epub 2013 Jan 8.

12.

Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.

Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ.

Cancer Res. 1999 Mar 15;59(6):1225-30.

13.

Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.

Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.

Res Rep Health Eff Inst. 2009 Mar;(139):5-71; discussion 73-89.

PMID:
19554969
14.

Comparison of circulating plasma DNA levels between lung cancer patients and healthy controls.

Yoon KA, Park S, Lee SH, Kim JH, Lee JS.

J Mol Diagn. 2009 May;11(3):182-5. doi: 10.2353/jmoldx.2009.080098. Epub 2009 Mar 26.

15.

Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.

Vinayanuwattikun C, Sriuranpong V, Tanasanvimon S, Chantranuwat P, Mutirangura A.

J Thorac Oncol. 2011 Nov;6(11):1818-25. doi: 10.1097/JTO.0b013e318226b46f.

PMID:
21964525
16.

A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers.

Church TR, Anderson KE, Caporaso NE, Geisser MS, Le CT, Zhang Y, Benoit AR, Carmella SG, Hecht SS.

Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):260-6. doi: 10.1158/1055-9965.EPI-08-0718.

17.

Circulating adiponectin levels and expression of adiponectin receptors in relation to lung cancer: two case-control studies.

Petridou ET, Mitsiades N, Gialamas S, Angelopoulos M, Skalkidou A, Dessypris N, Hsi A, Lazaris N, Polyzos A, Syrigos C, Brennan AM, Tseleni-Balafouta S, Mantzoros CS.

Oncology. 2007;73(3-4):261-9. doi: 10.1159/000127424. Epub 2008 Apr 17.

PMID:
18424891
18.

Dietary cryptoxanthin and reduced risk of lung cancer: the Singapore Chinese Health Study.

Yuan JM, Stram DO, Arakawa K, Lee HP, Yu MC.

Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):890-8.

19.

Drugs for preventing lung cancer in healthy people.

Caraballoso M, Sacristan M, Serra C, Bonfill X.

Cochrane Database Syst Rev. 2003;(2):CD002141. Review. Update in: Cochrane Database Syst Rev. 2012;10:CD002141.

PMID:
12804424
20.

Beta-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma.

Cook NR, Stampfer MJ, Ma J, Manson JE, Sacks FM, Buring JE, Hennekens CH.

Cancer. 1999 Nov 1;86(9):1783-92.

PMID:
10547552
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk